# Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

> **NCT00024544** · PHASE2 · COMPLETED · sponsor: **Facet Biotech** · enrollment: 120 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** anti-IL-4 monoclonal antibody (pascolizumab)

## Key facts

- **NCT ID:** NCT00024544
- **Lead sponsor:** Facet Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 120 (—)
- **Last updated:** 2012-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00024544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00024544, "Pilot Study in Patients With Symptomatic Steroid-Naive Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00024544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*